医学
阿达木单抗
银屑病性关节炎
贾纳斯激酶
药理学
关节炎
Janus激酶抑制剂
抗风湿药
抗风湿药物
肿瘤坏死因子α
肿瘤科
内科学
受体
作者
Iain B. McInnes,J. Anderson,Marina Magrey,Joseph F. Merola,Yi Liu,Mitsumasa Kishimoto,Sławomir Jeka,César Pacheco-Tena,Xin Wang,Liang Chen,Patrick Zueger,John Liu,Aileen L. Pangan,Frank Behrens
标识
DOI:10.1056/nejmoa2022516
摘要
The Janus kinase inhibitor upadacitinib is a potential treatment for psoriatic arthritis. The efficacy and safety of upadacitinib as compared with adalimumab, a tumor necrosis factor α inhibitor, in patients who have an inadequate response to nonbiologic disease-modifying antirheumatic drugs are unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI